News@UofTU of T researchers develop new generation CAR T-cells for cancer therapyNews@UofTWith CAR T-cell therapy one of the promising technologies emerging in targeted cancer treatment, University of Toronto scientists have taken a step forward in imp… Continue reading
Cord Blood Stem Cell Study Shows Promise for AutismPR Newswire (press release)The study, which was published this week in the medical journal Stem Cells Translational Medicine, involved 30 children and was conducted by Michael Chez, M.D., the primary i… Continue reading
NormanObserver.comCRISPR/Cas9 gene editors in the green on Gilead deal interestSeeking AlphaThe up move in biotechs notwithstanding, CRISPR/Cas9 gene editing players Intellia Therapeutics (NTLA +6.1%), Editas Medicine (EDIT +1.5%) and CRISPR Therapeuti… Continue reading
Curetoday.com |
Viruses May Be the Future of Boosting Immunotherapy in Brain Cancer
Curetoday.com In recent years, major advances have been made in the immunotherapy scape, as it has become instrumental in revolutionizing the way oncologists treat a variety of cancers. However, its success in patients with brain cancer has been extremely limited … Cancer injection eliminates tumors in miceFOX 4 News Breakthrough cancer ‘vaccine’ may eventually eliminate tumors in rapid, inexpensive way, researchers findGrand Forks Herald Human testing of new cancer vaccine underway after successful mice trialTechnoChops (press release) (blog) Іnsіdеr Cаr Nеws all 50 news articles » |
|
Abeona’s gene therapy candidate for Sanfilippo B shows encouraging effect in first patient; shares up 12%
Seeking Alpha Abeona Therapeutics (ABEO +11.6%) is up on modestly higher volume in response to its announcement of encouraging data from the first MPS IIIB (Sanfilippo syndrome type B) patient treated with gene therapy candidate ABO-101. MPS IIIB … Abeona Therapeutics Reports on Initial Safety and Biopotency Signals in MPS IIIB Gene Therapy Clinical TrialGlobeNewswire (press release) Why Abeona Therapeutics Jumped 14% on WednesdayMotley Fool Maxim Group Assigns a Buy Rating on Abeona TherapeuticsAnalyst Ratings BZ Weekly –StockNewsTimes all 22 news articles » |